On the subject of discussion just recently Capricor just Ann a...

On the subject of discussion just recently Capricor just Ann a raise of $23mil US

Capricor Therapeutics
Fri, 29 September 2023 at 7:35 pm AWST·4-min read


Capricor Therapeutics
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR),
a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced that it has entered into definitive agreements with its commercial partner, Nippon Shinyaku, Co., Ltd. and funds associated with Highbridge Capital Management, LLC. for the issuance and sale of 4,935,621 shares of its common stock in a registered direct offering. Each share of common stock offered was sold with a warrant to purchase one share of common stock at an exercise price of $5.70 per share. Each warrant will be exercisable beginning six months after issuance and will expire seven years from the date of issuance. The combined offering price per share of common stock and accompanying warrant is $4.66.

The closing of the offering is expected to occur on or about October 3, 2023, subject to the satisfaction of customary closing conditions.

The gross proceeds to the Company from the offering are expected to be approximately $23 million



Looks like the market didnt approve




The market has no mercy hence if and when we partner it had better be convincing

Capr dropped 50% more or less

https://au.finance.yahoo.com/news/capricor-therapeutics-announces-23-million-113500179.html